FORM OF REPRESENTATIVE’S WARRANT AGREEMENT Tharimmune, Inc.Warrant Agreement • November 17th, 2023 • Tharimmune, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 17th, 2023 Company IndustryTHIS WARRANT TO PURCHASE COMMON STOCK (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [__], 2023 (the “Initial Exercise Date”) and, in accordance with FINRA Rule 5110(g)(8)(A), prior to at 5:00 p.m. (New York time) on the date that is five (5) years following the Effective Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Tharimmune, Inc. (formerly Hillstream BioPharma, Inc.), a Delaware corporation (the “Company”), up to ______ shares of common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Warrant Shares”), as subject to adjustment hereunder. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Form of Underwriters’ Warrant AgreementWarrant Agreement • June 8th, 2022 • Lytus Technologies Holdings PTV. Ltd. • Services-computer processing & data preparation
Contract Type FiledJune 8th, 2022 Company IndustryTHIS WARRANT TO PURCHASE COMMON SHARES (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after _____________, 20___ (the “Initial Exercise Date”)2 and, in accordance with FINRA Rule 5110(f)(2)(G)(i), prior to at 5:00 p.m. (New York time) on _____________, 202_3 (the “Termination Date”), but not thereafter, to subscribe for and purchase from Lytus Technologies Holdings PTV. LTD., a British Virgin Islands corporation (the “Company”), up to _______________ common shares, par value $0.01 per share (the “Common Shares”), of the Company (the “Warrant Shares”), as subject to adjustment hereunder. The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).